MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 123933 | Name: CpCDPK1/TgCDPK1-IN-3
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

CpCDPK1/TgCDPK1-IN-3 (Compound 20) is a CpCDPK1 and TgCDPK1 inhibitor

Chemical Structure

CpCDPK1/TgCDPK1-IN-3
CpCDPK1/TgCDPK1-IN-3
CAS#1092788-87-8

Theoretical Analysis

MedKoo Cat#: 123933

Name: CpCDPK1/TgCDPK1-IN-3

CAS#: 1092788-87-8

Chemical Formula: C17H18N6

Exact Mass: 306.1593

Molecular Weight: 306.37

Elemental Analysis: C, 66.65; H, 5.92; N, 27.43

Price and Availability

Size Price Availability Quantity
100mg USD 1,250.00 2 Weeks
200mg USD 1,950.00 2 Weeks
500mg USD 3,450.00 2 Weeks
1g USD 4,650.00 2 Weeks
2g USD 6,850.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
CpCDPK1/TgCDPK1-IN-3; Compound 20; CpCDPK1; TgCDPK1
IUPAC/Chemical Name
1-isopropyl-3-(1-methyl-1H-indol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
InChi Key
SPUWUOGLPPVXCW-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H18N6/c1-10(2)23-17-14(16(18)19-9-20-17)15(21-23)12-4-5-13-11(8-12)6-7-22(13)3/h4-10H,1-3H3,(H2,18,19,20)
SMILES Code
NC1=C2C(N(C(C)C)N=C2C3=CC4=C(N(C)C=C4)C=C3)=NC=N1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 306.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shu F, Li Y, Chu W, Chen X, Zhang Z, Guo Y, Feng Y, Xiao L, Li N. Characterization of Calcium-Dependent Protein Kinase 2A, a Potential Drug Target Against Cryptosporidiosis. Front Microbiol. 2022 Apr 25;13:883674. doi: 10.3389/fmicb.2022.883674. PMID: 35558125; PMCID: PMC9090282. 2: Artz JD, Wernimont AK, Allali-Hassani A, Zhao Y, Amani M, Lin YH, Senisterra G, Wasney GA, Fedorov O, King O, Roos A, Lunin VV, Qiu W, Finerty P Jr, Hutchinson A, Chau I, von Delft F, MacKenzie F, Lew J, Kozieradzki I, Vedadi M, Schapira M, Zhang C, Shokat K, Heightman T, Hui R. The Cryptosporidium parvum kinome. BMC Genomics. 2011 Sep 30;12:478. doi: 10.1186/1471-2164-12-478. PMID: 21962082; PMCID: PMC3227725. 3: Hulverson MA, Vinayak S, Choi R, Schaefer DA, Castellanos-Gonzalez A, Vidadala RSR, Brooks CF, Herbert GT, Betzer DP, Whitman GR, Sparks HN, Arnold SLM, Rivas KL, Barrett LK, White AC Jr, Maly DJ, Riggs MW, Striepen B, Van Voorhis WC, Ojo KK. Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy. J Infect Dis. 2017 Apr 15;215(8):1275-1284. doi: 10.1093/infdis/jix120. Erratum in: J Infect Dis. 2018 Jan 4;217(2):340. PMID: 28329187; PMCID: PMC5853794. 4: Su J, Shen Y, Li N, Li Y, Zhang Z, Xiao L, Guo Y, Feng Y. Comparative Characterization of CpCDPK1 and CpCDPK9, Two Potential Drug Targets Against Cryptosporidiosis. Microorganisms. 2022 Feb 1;10(2):333. doi: 10.3390/microorganisms10020333. PMID: 35208789; PMCID: PMC8875172.

View History

RG 12525

RG 12525

Monoethanolamine phosphate

Monoethanolamine phosphate

Desipramine Free Base

Desipramine Free Base

Pemirolast Na

Pemirolast Na